Speakers

coming soon

coming soon

Prof. Dr. Simon N. Jacob
Technical University of Munich, TUM School of Medicine and Health

Prof. Jacob (b. 1977) is a neurologist and neurophysiologist. His research focusses on the cellular and circuit basis of cognitive brain functions. Based on his experimental work, Prof. Jacob is developing technologies that can contribute to improving treatments for disorders in the domains of perception, memory and language.

Prof. Jacob studied medicine in Freiburg and Heidelberg, at University College London (UK) and at Harvard University (USA) as a fellow of the German National Academic Foundation. He obtained his medical doctorate degree in 2006 based on experimental neurophysiological work conducted at Yale University (USA). Prof. Jacob was a postdoctoral researcher at the Center for Integrative Neuroscience in Tübingen and qualified as a board-certified neurologist after training in Tübingen and at the Charité in Berlin. In 2015, Prof. Jacob moved to TUM where he established an interdisciplinary research group investigating the neuronal mechanisms of cognitive brain functions. He was appointed professor for Translational Neurotechnology in 2019.

Awards

• ERC Consolidator Grant (2024)
• Early Excellence Academy, SyNergy Cluster for Systems Neurology (2023)
• Speaker TUM Innovation Network NEUROTECH (2021-2026)
• ERC Starting Grant (2017)
• Charité Clinical Scientist Award (2014)

Dr. med. Kai Joachimsen, MD, MBA
General Manager BPI e.V.

Licensed and PhD-qualified physician as well as a certified business economist.
He completed his medical studies in Marburg, Münster, and Vienna. His experimental doctoral thesis was in radiology and cardiology (magnetic resonance imaging in cardiomyopathies).
He received his Master of Business Administration (MBA) from Northwestern University Kellogg in Chicago and WHU in Vallendar.
He held senior positions in the pharmaceutical industry at GlaxoWellcome/GSK as Head of Marketing & Business Team Respiratory, was Head of Respiratory & Cardiovascular at Boehringer Ingelheim, and also served as Business Unit Leader, Head of New Commercial Model, EMEAC Franchise Leader, and Global Franchise Leader at MSD/Merck Inc. in Munich and New Jersey. In 2012, he took over the sole management of Chiesi GmbH Germany and additionally as CEO in the private equity sector.
Since 2018, he has been with BPI e.V. and since 2019, he has been serving as Chief Executive Officer and member of the board.

coming soon

Prof. Dr. med. Dr. h.c. Ralf Huss

Managing Director of Bio^M Biotech Development GmbH and spokesperson for the Bavarian Biotechnology Cluster

Ralf Huss completed his medical studies with a doctorate in immunology at Friedrich-Alexander University (FAU) in Erlangen-Nuremberg. After research stays in Zurich (Switzerland) and Seattle (USA), he became a specialist in pathology and adjunct professor at Ludwig Maximilian University (LMU) in Munich; at the same time, he was an honorary professor at University College Dublin (Ireland) and finally a lecturer in biomaterials at the Faculty of Chemistry (School of Natural Sciences) at the Technical University of Munich (TUM). After working for Roche and small to medium-sized companies in the field of biotechnology and digital diagnostics, his focus as a visiting professor at the Institute for Regenerative Medicine at Wake Forest University School of Medicine in Winston-Salem (USA) was on topics related to regenerative medicine and the use of genetically modified stem cells in the treatment of numerous diseases. In recent years, his research interests have increasingly expanded to include the application of data and AI in clinical and biopharmaceutical research and the entire field of ‘digital medicine’. He is a member of numerous national and international professional associations, advisory boards and curatorial boards.

On 1 January 2023, Prof. Huss took over as managing director of BioM Biotech Cluster Development GmbH, which has been the network organisation for the biotechnology industry in Munich and Bavaria since 1997.

Matthias Meergans, MD, PhD, MSc.

• Executive Director, Research and Development at Association of Research-Based Pharmaceutical Companies (vfa)
• 20 years of experience in global pharmaceutical companies across Medicine, R&D, and Marketing, holding local and international roles.
• Lecturer at the Goethe Business School/Frankfurt (Pharma MBA)
• Board Certificate in Internal Medicine; Master of Science (MSc) in Pharmaceutical Medicine
• Studied Medicine in Berlin and Tübingen

coming soon

coming soon

coming soon

coming soon